{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:54:42Z","timestamp":1791665682112,"version":"4.3.4"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202006550003"],"award-info":[{"award-number":["202006550003"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG046171"],"award-info":[{"award-number":["R01AG046171"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National institute of aging","award":["RF1AG051550"],"award-info":[{"award-number":["RF1AG051550"]}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["DAOU16AMPA"],"award-info":[{"award-number":["DAOU16AMPA"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["175.2019.032"],"award-info":[{"award-number":["175.2019.032"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mounting evidence implicates inflammation as a key factor in Alzheimer\u2019s disease (AD) development. We previously identified pro-inflammatory soluble epoxide hydrolase (sEH) metabolites to be elevated in plasma and CSF of AD participants and to be associated with lower cognition in non-AD subjects. Soluble epoxide hydrolase is a key enzyme converting anti-inflammatory epoxy fatty acids to pro-inflammatory diols, reported to be elevated in multiple cardiometabolic disorders. Here we analyzed over 700 fasting plasma samples from the baseline of Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) 2\/GO study. We applied targeted mass spectrometry method to provide absolute quantifications of over 150 metabolites from oxylipin and endocannabinoids pathway, interrogating the role for inflammation\/immune dysregulation and the key enzyme soluble epoxide hydrolase in AD. We provide further insights into the regulation of this pathway in different disease stages, APOE genotypes and between sexes. Additionally, we investigated in mild cognitive impaired (MCI) participants, metabolic signatures that inform about resilience to progression and conversion to AD. Key findings include I) confirmed disruption in this key central pathway of inflammation and pointed to dysregulation of sEH in AD with sex and disease stage differences; II) identified markers of disease progression and cognitive resilience using sex and ApoE genotype stratified analysis highlighting an important role for bile acids, lipid peroxidation and stress response hormone cortisol. In conclusion, we provide molecular insights into a central pathway of inflammation and links to cognitive dysfunction, suggesting novel therapeutic approaches that are based on targeting inflammation tailored for subgroups of individuals based on their sex, APOE genotype and their metabolic profile.<\/jats:p>","DOI":"10.1186\/s13195-025-01939-9","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T02:34:33Z","timestamp":1767753273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer\u2019s disease\u2014finding from Alzheimer\u2019s Disease Neuroimaging Initiative"],"prefix":"10.1186","volume":"18","author":[{"given":"Kamil","family":"Borkowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alida","family":"Kindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuanyi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"Blach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Kaddurah-Daouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hankemeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"issue":"3","key":"1939_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/s0197-4580(00)00124-x","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O\u2019Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T. Inflammation and Alzheimer\u2019s disease. Neurobiol Aging. 2000;21(3):383\u2013421. https:\/\/doi.org\/10.1016\/s0197-4580(00)00124-x. PubMedPMID:10858586;PMCID:PMC3887148.","journal-title":"Neurobiol Aging"},{"key":"1939_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1305790","volume":"15","author":"S Tan","year":"2023","unstructured":"Tan S, Chen W, Kong G, Wei L, Xie Y. Peripheral inflammation and neurocognitive impairment: correlations, underlying mechanisms, and therapeutic implications. Front Aging Neurosci. 2023;15:1305790. https:\/\/doi.org\/10.3389\/fnagi.2023.1305790.","journal-title":"Front Aging Neurosci"},{"key":"1939_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14082041","author":"DV Chistyakov","year":"2022","unstructured":"Chistyakov DV, Guryleva MV, Stepanova ES, Makarenkova LM, Ptitsyna EV, Goriainov SV, Nikolskaya AI, Astakhova AA, Klimenko AS, Bezborodova OA, Rasskazova EA, Potanina OG, Abramovich RA, Nemtsova ER, Sergeeva MG. Multi-omics approach points to the importance of oxylipins metabolism in early-stage breast cancer. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14082041. PubMed PMID: 35454947; PMCID: PMC9032865.","journal-title":"Cancers (Basel)"},{"issue":"11","key":"1939_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048852","volume":"7","author":"D Grapov","year":"2012","unstructured":"Grapov D, Adams SH, Pedersen TL, Garvey WT, Newman JW. Type 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoids. PLoS ONE. 2012;7(11):e48852. https:\/\/doi.org\/10.1371\/journal.pone.0048852.","journal-title":"PLoS ONE"},{"issue":"1","key":"1939_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/oby.23282","volume":"30","author":"L Jurado-Fasoli","year":"2022","unstructured":"Jurado-Fasoli L, Di X, Kohler I, Osuna-Prieto FJ, Hankemeier T, Krekels E, et al. Omega-6 and omega-3 oxylipins as potential markers of cardiometabolic risk in young adults. Obesity. 2022;30(1):50\u201361. https:\/\/doi.org\/10.1002\/oby.23282.","journal-title":"Obesity"},{"key":"1939_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plefa.2017.10.006","volume":"128","author":"GC Shearer","year":"2018","unstructured":"Shearer GC, Borkowski K, Puumala SL, Harris WS, Pedersen TL, Newman JW. Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2018;128:1\u201310. https:\/\/doi.org\/10.1016\/j.plefa.2017.10.006. PubMed PMID: 29413356.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"7","key":"1939_CR7","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/aps.2018.24","volume":"39","author":"MA Nayeem","year":"2018","unstructured":"Nayeem MA. Role of oxylipins in cardiovascular diseases. Acta Pharmacol Sin. 2018;39(7):1142\u201354. https:\/\/doi.org\/10.1038\/aps.2018.24.","journal-title":"Acta Pharmacol Sin"},{"key":"1939_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.645786","volume":"8","author":"DE Le","year":"2021","unstructured":"Le DE, Garcia-Jaramillo M, Bobe G, Alcazar Magana A, Vaswani A, Minnier J, et al. Plasma oxylipins: a potential risk assessment tool in atherosclerotic coronary artery disease. Front Cardiovasc Med. 2021;8:645786. https:\/\/doi.org\/10.3389\/fcvm.2021.645786.","journal-title":"Front Cardiovasc Med"},{"key":"1939_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.663869","author":"CB McReynolds","year":"2021","unstructured":"McReynolds CB, Cortes-Puch I, Ravindran R, Khan IH, Hammock BG, Shih P-aB, et al. Plasma linoleate diols are potential biomarkers for severe COVID-19 infections. Front Physiol. 2021. https:\/\/doi.org\/10.3389\/fphys.2021.663869.","journal-title":"Front Physiol"},{"key":"1939_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.freeradbiomed.2022.01.021","volume":"180","author":"D Biagini","year":"2022","unstructured":"Biagini D, Franzini M, Oliveri P, Lomonaco T, Ghimenti S, Bonini A, et al. MS-based targeted profiling of oxylipins in COVID-19: a new insight into inflammation regulation. Free Radical Biol Med. 2022;180:236\u201343.","journal-title":"Free Radical Biol Med"},{"key":"1939_CR11","doi-asserted-by":"crossref","unstructured":"Karu N, Kindt A, Lamont L, van Gammeren AJ, Ermens AAM, Harms AC, Portengen L, Vermeulen RCH, Dik WA, Langerak AW, van der Velden VHJ, Hankemeier T. Plasma Oxylipins and Their Precursors Are Strongly Associated with COVID-19 Severity and with Immune Response Markers. Metabolites. 2022;127.","DOI":"10.3390\/metabo12070619"},{"issue":"11","key":"1939_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239115","volume":"15","author":"K Borkowski","year":"2020","unstructured":"Borkowski K, Newman JW, Aghaeepour N, Mayo JA, Blazenovic I, Fiehn O, Stevenson DK, Shaw GM, Carmichael SL. Mid-gestation serum lipidomic profile associations with spontaneous preterm birth are influenced by body mass index. PLoS ONE. 2020;15(11): e0239115. https:\/\/doi.org\/10.1371\/journal.pone.0239115. PubMedPMID:33201881;PMCID:PMC7671555.","journal-title":"PLoS ONE"},{"key":"1939_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2021.102251","volume":"166","author":"M Svenvik","year":"2021","unstructured":"Svenvik M, Raffetseder J, Brudin L, Lindberg R, Blomberg M, Axelsson D, Jenmalm MC, Ernerudh J, Nording ML. Plasma oxylipin levels associated with preterm birth in preterm labor(). Prostaglandins Leukot Essent Fatty Acids. 2021;166: 102251. https:\/\/doi.org\/10.1016\/j.plefa.2021.102251. PubMed PMID: 33626402.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"5","key":"1939_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3945\/an.114.007732","volume":"6","author":"M Gabbs","year":"2015","unstructured":"Gabbs M, Leng S, Devassy JG, Monirujjaman M, Aukema HM. Advances in our understanding of oxylipins derived from dietary PUFAs. Adv Nutr. 2015;6(5):513\u201340. https:\/\/doi.org\/10.3945\/an.114.007732.","journal-title":"Adv Nutr"},{"key":"1939_CR15","doi-asserted-by":"publisher","first-page":"830","DOI":"10.5604\/17322693.1213898","volume":"70","author":"M Biernacki","year":"2016","unstructured":"Biernacki M, Skrzydlewska E. Metabolism of endocannabinoids. Postepy Hig Med Dosw (Online). 2016;70:830\u201343. https:\/\/doi.org\/10.5604\/17322693.1213898. PubMed PMID: 27516570.","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"2","key":"1939_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neurobiolaging.2007.06.012","volume":"30","author":"Y Yoshida","year":"2009","unstructured":"Yoshida Y, Yoshikawa A, Kinumi T, Ogawa Y, Saito Y, Ohara K, et al. Hydroxyoctadecadienoic acid and oxidatively modified peroxiredoxins in the blood of Alzheimer\u2019s disease patients and their potential as biomarkers. Neurobiol Aging. 2009;30(2):174\u201385.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1939_CR17","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1007\/s12035-017-0527-1","volume":"55","author":"S Shekhar","year":"2018","unstructured":"Shekhar S, Yadav SK, Rai N, Kumar R, Yadav Y, Tripathi M, Dey AB, Dey S. 5-LOX in Alzheimer\u2019s disease: potential serum marker and in vitro evidences for rescue of neurotoxicity by its inhibitor YWCS. Mol Neurobiol. 2018;55(4):2754\u201362. https:\/\/doi.org\/10.1007\/s12035-017-0527-1. PubMed PMID: 28451886.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"1939_CR18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0306-4522(98)00218-8","volume":"87","author":"G Pasinetti","year":"1998","unstructured":"Pasinetti G, Aisen P. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer\u2019s disease brain. Neuroscience. 1998;87(2):319\u201324.","journal-title":"Neuroscience"},{"issue":"1","key":"1939_CR19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13195-022-01084-7","volume":"14","author":"B Ebright","year":"2022","unstructured":"Ebright B, Assante I, Poblete RA, Wang S, Duro MV, Bennett DA, et al. Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer\u2019s dementia. Alzheimer\u2019s Research & Therapy. 2022;14(1):152. https:\/\/doi.org\/10.1186\/s13195-022-01084-7.","journal-title":"Alzheimer's Research & Therapy"},{"key":"1939_CR20","unstructured":"Ikonomovic MD, Abrahamson Ee Fau - Uz T, Uz T Fau - Manev H, Manev H Fau - Dekosky ST, Dekosky ST. Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease(0022\u20131554 (Print))."},{"issue":"4","key":"1939_CR21","doi-asserted-by":"publisher","DOI":"10.1096\/fj.07-9131.com","volume":"22","author":"O Firuzi","year":"2008","unstructured":"Firuzi O, Zhuo J, Chinnici CM, Wisniewski T, Pratic\u00f2 D. 5-lipoxygenase gene disruption reduces amyloid-\u03b2 pathology in a mouse model of Alzheimer\u2019s disease. FASEB J. 2008;22(4):1169.","journal-title":"FASEB J"},{"key":"1939_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.brainresbull.2016.03.010","volume":"126","author":"J Chu","year":"2016","unstructured":"Chu J, Pratic\u00f2 D. The 5-lipoxygenase as modulator of Alzheimer\u2019s \u03b3-secretase and therapeutic target. Brain Res Bull. 2016;126:207\u201312.","journal-title":"Brain Res Bull"},{"issue":"1","key":"1939_CR23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1471-4159.2007.04742.x","volume":"103","author":"F Succol","year":"2007","unstructured":"Succol F, Pratic\u00f2 D. A role for 12\/15 lipoxygenase in the amyloid \u03b2 precursor protein metabolism. J Neurochem. 2007;103(1):380\u20137. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04742.x.","journal-title":"J Neurochem"},{"issue":"1","key":"1939_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/ana.22625","volume":"71","author":"J Chu","year":"2012","unstructured":"Chu J, Zhuo JM, Pratic\u00f2 D. Transcriptional regulation of \u03b2secretase-1 by 12\/15-lipoxygenase results in enhanced amyloidogenesis and cognitive impairments. Ann Neurol. 2012;71(1):57\u201367.","journal-title":"Ann Neurol"},{"issue":"3","key":"1939_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.tips.2015.01.005","volume":"36","author":"YB Joshi","year":"2015","unstructured":"Joshi YB, Giannopoulos PF, Pratic\u00f2 D. The 12\/15-lipoxygenase as an emerging therapeutic target for Alzheimer\u2019s disease. Trends Pharmacol Sci. 2015;36(3):181\u20136. https:\/\/doi.org\/10.1016\/j.tips.2015.01.005.","journal-title":"Trends Pharmacol Sci"},{"key":"1939_CR26","unstructured":"Xiang Z, Ho L Fau - Yemul S, Yemul S Fau - Zhao Z, Zhao Z Fau - Qing W, Qing W Fau - Pompl P, Pompl P Fau - Kelley K, Kelley K Fau - Dang A, Dang A Fau - Qing W, Qing W Fau - Teplow D, Teplow D Fau - Pasinetti GM, Pasinetti GM. Cyclooxygenase-2 promotes amyloid plaque deposition in a mouse model of Alzheimer's disease neuropathology(1052\u20132166 (Print))."},{"issue":"7","key":"1939_CR27","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1093\/brain\/aww117","volume":"139","author":"NS Woodling","year":"2016","unstructured":"Woodling NS, Colas D, Wang Q, Minhas P, Panchal M, Liang X, et al. Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer\u2019s disease model mice. Brain. 2016;139(7):2063\u201381.","journal-title":"Brain"},{"issue":"4","key":"1939_CR28","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s13311-020-00854-1","volume":"17","author":"C Grinan-Ferre","year":"2020","unstructured":"Grinan-Ferre C, Codony S, Pujol E, Yang J, Leiva R, Escolano C, Puigoriol-Illamola D, Companys-Alemany J, Corpas R, Sanfeliu C, Perez B, Loza MI, Brea J, Morisseau C, Hammock BD, Vazquez S, Pallas M, Galdeano C. Pharmacological inhibition of soluble epoxide hydrolase as a new therapy for Alzheimer\u2019s disease. Neurotherapeutics. 2020;17(4):1825\u201335. https:\/\/doi.org\/10.1007\/s13311-020-00854-1. PubMed PMID: 32488482; PMCID: PMC7851240.","journal-title":"Neurotherapeutics"},{"key":"1939_CR29","doi-asserted-by":"publisher","unstructured":"Ghosh AA-O, Comerota MM, Wan D, Chen F, Propson NE, Hwang SA-OX, Hammock BD, Zheng HA-O. An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer's disease. LID - https:\/\/doi.org\/10.1126\/scitranslmed.abb1206 LID - eabb1206(1946\u20136242 (Electronic)).","DOI":"10.1126\/scitranslmed.abb1206"},{"key":"1939_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.06.026","author":"N Mast","year":"2017","unstructured":"Mast N, Saadane A, Valencia-Olvera A, Constans J, Maxfield E, Arakawa H, Li Y, Landreth G, Pikuleva IA. Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer\u2019s disease. Neuropharmacology. 2017. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.06.026. (1873\u20137064 (Electronic)).","journal-title":"Neuropharmacology"},{"issue":"6","key":"1939_CR31","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1074\/jbc.M113.532846","volume":"289","author":"N Mast","year":"2014","unstructured":"Mast N, Li Y, Linger M, Clark M, Wiseman J, Pikuleva IA. Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice*. J Biol Chem. 2014;289(6):3529\u201338. https:\/\/doi.org\/10.1074\/jbc.M113.532846.","journal-title":"J Biol Chem"},{"key":"1939_CR32","doi-asserted-by":"publisher","unstructured":"Ruiz-P\u00e9rez G, Ruiz de Mart\u00edn Esteban S, Marqu\u00e9s S, Aparicio N, Grande MT, Benito-Cuesta I, Mart\u00ednez-Relimpio AM, Arnanz MA, Tol\u00f3n RM, Posada-Ayala M, Cravatt BF, Esteban JA, Romero J, Palenzuela R. Potentiation of amyloid beta phagocytosis and amelioration of synaptic dysfunction upon FAAH deletion in a mouse model of Alzheimer's disease. Journal of Neuroinflammation. 2021;18(1):223. https:\/\/doi.org\/10.1186\/s12974-021-02276-y.","DOI":"10.1186\/s12974-021-02276-y"},{"issue":"1","key":"1939_CR33","doi-asserted-by":"publisher","first-page":"22429","DOI":"10.1038\/srep22429","volume":"6","author":"W Yan","year":"2016","unstructured":"Yan W, Yun Y, Ku T, Li G, Sang N. NO 2 inhalation promotes Alzheimer\u2019s disease-like progression: cyclooxygenase-2-derived prostaglandin E 2 modulation and monoacylglycerol lipase inhibition-targeted medication. Sci Rep. 2016;6(1):22429. https:\/\/doi.org\/10.1038\/srep22429.","journal-title":"Sci Rep"},{"key":"1939_CR34","unstructured":"Bajaj SA-O, Zameer S, Jain S, Yadav V, Vohora D. Effect of the MAGL\/FAAH Dual Inhibitor JZL-195 on Streptozotocin-Induced Alzheimer's Disease-like Sporadic Dementia in Mice with an Emphasis on A\u03b2, HSP-70, Neuroinflammation, and Oxidative Stress(1948-7193 (Electronic))."},{"key":"1939_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neulet.2015.03.024","volume":"593","author":"H Yan","year":"2015","unstructured":"Yan H, Kong Y, He B, Huang M, Li J, Zheng J, et al. CYP2J2 rs890293 polymorphism is associated with susceptibility to Alzheimer\u2019s disease in the Chinese Han population. Neurosci Lett. 2015;593:56\u201360. https:\/\/doi.org\/10.1016\/j.neulet.2015.03.024.","journal-title":"Neurosci Lett"},{"key":"1939_CR36","doi-asserted-by":"publisher","unstructured":"Qu T, Manev R, Manev H. 5-Lipoxygenase (5-LOX) promoter polymorphism in patients with early-onset and late-onset Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 2001;13(2):304-5. https:\/\/doi.org\/10.1176\/jnp.13.2.304. PubMed PMID: 11449041.","DOI":"10.1176\/jnp.13.2.304"},{"issue":"5","key":"1939_CR37","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s10072-012-1115-9","volume":"34","author":"W Tang","year":"2013","unstructured":"Tang W, He M, Yang B, Wei K, Yin M, Zhang L. Association study of polymorphisms in the cyclooxygenase-2 gene and Alzheimer\u2019s disease risk in Chinese. Neurol Sci. 2013;34(5):695\u20139. https:\/\/doi.org\/10.1007\/s10072-012-1115-9. PubMed PMID: 22622868.","journal-title":"Neurol Sci"},{"key":"1939_CR38","doi-asserted-by":"publisher","unstructured":"Toledo JB, Arnold M, Kastenmuller G, Chang R, Baillie RA, Han X, Thambisetty M, Tenenbaum JD, Suhre K, Thompson JW, John-Williams LS, MahmoudianDehkordi S, Rotroff DM, Jack JR, Motsinger-Reif A, Risacher SL, Blach C, Lucas JE, Massaro T, Louie G, Zhu H, Dallmann G, Klavins K, Koal T, Kim S, Nho K, Shen L, Casanova R, Varma S, Legido-Quigley C, Moseley MA, Zhu K, Henrion MYR, van der Lee SJ, Harms AC, Demirkan A, Hankemeier T, van Duijn CM, Trojanowski JQ, Shaw LM, Saykin AJ, Weiner MW, Doraiswamy PM, Kaddurah-Daouk R, Alzheimer's Disease Neuroimaging I, the Alzheimer Disease Metabolomics C. Metabolic network failures in Alzheimer's disease: A biochemical road map. Alzheimers Dement. 2017;13(9):965-84. https:\/\/doi.org\/10.1016\/j.jalz.2017.01.020. PubMed PMID: 28341160; PMCID: PMC5866045.","DOI":"10.1016\/j.jalz.2017.01.020"},{"issue":"1","key":"1939_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-67177-5","volume":"14","author":"N Liang","year":"2024","unstructured":"Liang N, Nho K, Newman JW, Arnold M, Huynh K, Meikle PJ, Borkowski K, Kaddurah-Daouk R, Alzheimer\u2019s Disease Metabolomics C. Peripheral inflammation is associated with brain atrophy and cognitive decline linked to mild cognitive impairment and Alzheimer\u2019s disease. Sci Rep. 2024;14(1): 17423. https:\/\/doi.org\/10.1038\/s41598-024-67177-5. PubMed PMID: 39075118; PMCID: PMC11286782.","journal-title":"Sci Rep"},{"key":"1939_CR40","doi-asserted-by":"publisher","unstructured":"Chen T, Wang L, Xie G, Kristal BS, Zheng X, Sun T, Arnold M, Louie G, Li M, Wu L, Mahmoudiandehkordi S, Sniatynski MJ, Borkowski K, Guo Q, Kuang J, Wang J, Nho K, Ren Z, Kueider-Paisley A, Blach C, Kaddurah-Daouk R, Jia W, Alzheimer's Disease Neuroimaging I, the Alzheimer Disease Metabolomics C. Serum Bile Acids Improve Prediction of Alzheimer's Progression in a Sex-Dependent Manner. Adv Sci (Weinh). 2024;11(9):e2306576. https:\/\/doi.org\/10.1002\/advs.202306576. PubMed PMID: 38093507; PMCID: PMC10916590.","DOI":"10.1002\/advs.202306576"},{"key":"1939_CR41","doi-asserted-by":"publisher","unstructured":"Amin N, Liu J, Bonnechere B, MahmoudianDehkordi S, Arnold M, Batra R, Chiou YJ, Fernandes M, Ikram MA, Kraaij R, Krumsiek J, Newby D, Nho K, Radjabzadeh D, Saykin AJ, Shi L, Sproviero W, Winchester L, Yang Y, Nevado-Holgado AJ, Kastenmuller G, Kaddurah-Daouk R, van Duijn CM. Interplay of Metabolome and Gut Microbiome in Individuals With Major Depressive Disorder vs Control Individuals. JAMA Psychiatry. 2023;80(6):597-609. https:\/\/doi.org\/10.1001\/jamapsychiatry.2023.0685. PubMed PMID: 37074710; PMCID: PMC10116384.","DOI":"10.1001\/jamapsychiatry.2023.0685"},{"issue":"1","key":"1939_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-98640-2","volume":"11","author":"K Borkowski","year":"2021","unstructured":"Borkowski K, Taha AY, Pedersen TL, De Jager PL, Bennett DA, Arnold M, et al. Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification. Sci Rep. 2021;11(1):18964. https:\/\/doi.org\/10.1038\/s41598-021-98640-2.","journal-title":"Sci Rep"},{"issue":"1","key":"1939_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00893-6","volume":"13","author":"K Borkowski","year":"2021","unstructured":"Borkowski K, Pedersen TL, Seyfried NT, Lah JJ, Levey AI, Hales CM, et al. Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer\u2019s disease. Alzheimers Res Ther. 2021;13(1):149. https:\/\/doi.org\/10.1186\/s13195-021-00893-6.","journal-title":"Alzheimers Res Ther"},{"key":"1939_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2024.342348","volume":"1297","author":"W Yang","year":"2024","unstructured":"Yang W, Schoeman JC, Di X, Lamont L, Harms AC, Hankemeier T. A comprehensive UHPLC-MS\/MS method for metabolomics profiling of signaling lipids: markers of oxidative stress, immunity and inflammation. Anal Chim Acta. 2024;1297:342348. https:\/\/doi.org\/10.1016\/j.aca.2024.342348.","journal-title":"Anal Chim Acta"},{"key":"1939_CR45","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.aca.2020.11.019","volume":"1143","author":"TL Pedersen","year":"2021","unstructured":"Pedersen TL, Gray IJ, Newman JW. Plasma and serum oxylipin, endocannabinoid, bile acid, steroid, fatty acid and nonsteroidal anti-inflammatory drug quantification in a 96-well plate format. Anal Chim Acta. 2021;1143:189\u2013200. https:\/\/doi.org\/10.1016\/j.aca.2020.11.019. PubMed PMID: 33384117.","journal-title":"Anal Chim Acta"},{"issue":"1","key":"1939_CR46","doi-asserted-by":"publisher","first-page":"13752","DOI":"10.1038\/s41598-023-39737-8","volume":"13","author":"K Borkowski","year":"2023","unstructured":"Borkowski K, Seyfried NT, Arnold M, Lah JJ, Levey AI, Hales CM, et al. Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism. Sci Rep. 2023;13(1):13752.","journal-title":"Sci Rep"},{"key":"1939_CR47","doi-asserted-by":"publisher","unstructured":"Higginbotham L, Ping L, Dammer EB, Duong DM, Zhou M, Gearing M, Hurst C, Glass JD, Factor SA, Johnson ECB, Hajjar I, Lah JJ, Levey AI, Seyfried NT. Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease. Sci Adv. 2020;6(43). https:\/\/doi.org\/10.1126\/sciadv.aaz9360. PubMed PMID: 33087358; PMCID: PMC7577712.","DOI":"10.1126\/sciadv.aaz9360"},{"issue":"5","key":"1939_CR48","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jalz.2015.09.009","volume":"12","author":"T Bittner","year":"2016","unstructured":"Bittner T, Zetterberg H, Teunissen CE, Ostlund RE Jr, Militello M, Andreasson U, Hubeek I, Gibson D, Chu DC, Eichenlaub U, Heiss P, Kobold U, Leinenbach A, Madin K, Manuilova E, Rabe C, Blennow K. Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of beta-amyloid (1\u201342) in human cerebrospinal fluid. Alzheimers Dement. 2016;12(5):517\u201326. https:\/\/doi.org\/10.1016\/j.jalz.2015.09.009. PubMed PMID: 26555316.","journal-title":"Alzheimers Dement"},{"key":"1939_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.clinbiochem.2019.05.006","volume":"72","author":"LM Shaw","year":"2019","unstructured":"Shaw LM, Hansson O, Manuilova E, Masters CL, Doecke JD, Li QX, Rutz S, Widmann M, Leinenbach A, Blennow K. Method comparison study of the Elecsys(R) beta-Amyloid (1\u201342) CSF assay versus comparator assays and LC-MS\/MS. Clin Biochem. 2019;72:7\u201314. https:\/\/doi.org\/10.1016\/j.clinbiochem.2019.05.006. PubMed PMID: 31129181.","journal-title":"Clin Biochem"},{"key":"1939_CR50","doi-asserted-by":"publisher","unstructured":"Watson CM, Dammer EB, Ping L, Duong DM, Modeste E, Carter EK, Johnson ECB, Levey AI, Lah JJ, Roberts BR, Seyfried NT. Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Protein Biomarkers in Alzheimer's Disease. Sci Data. 2023;10(1):261. https:\/\/doi.org\/10.1038\/s41597-023-02158-3. PubMed PMID: 37160957; PMCID: PMC10170100.","DOI":"10.1038\/s41597-023-02158-3"},{"issue":"2","key":"1939_CR51","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaf121","volume":"7","author":"R Tandon","year":"2025","unstructured":"Tandon R, Zhao L, Watson CM, Sarkar N, Elmor M, Heilman C, Sanders K, Hales CM, Yang H, Loring DW, Goldstein FC, Hanfelt JJ, Duong DM, Johnson ECB, Wingo AP, Wingo TS, Roberts BR, Seyfried NT, Levey AI, Lah JJ, Mitchell CS. Stratifying risk of Alzheimer\u2019s disease in healthy middle-aged individuals with machine learning. Brain Commun. 2025;7(2): fcaf121. https:\/\/doi.org\/10.1093\/braincomms\/fcaf121. PubMed PMID: 40226382; PMCID: PMC11986205.","journal-title":"Brain Commun"},{"key":"1939_CR52","doi-asserted-by":"publisher","unstructured":"Crane PK, Carle A, Gibbons LE, Insel P, Mackin RS, Gross A, Jones RN, Mukherjee S, Curtis SM, Harvey D, Weiner M, Mungas D, Alzheimer's Disease Neuroimaging I. Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI). Brain Imaging Behav. 2012;6(4):502\u201316. https:\/\/doi.org\/10.1007\/s11682-012-9186-z. PubMed PMID: 22782295; PMCID: PMC3806057.","DOI":"10.1007\/s11682-012-9186-z"},{"key":"1939_CR53","doi-asserted-by":"publisher","unstructured":"Batra R, Arnold M, Worheide MA, Allen M, Wang X, Blach C, Levey AI, Seyfried NT, Ertekin-Taner N, Bennett DA, Kastenmuller G, Kaddurah-Daouk RF, Krumsiek J, Alzheimer's Disease Metabolomics C. The landscape of metabolic brain alterations in Alzheimer's disease. Alzheimers Dement. 2023;19(3):980-98. https:\/\/doi.org\/10.1002\/alz.12714. PubMed PMID: 35829654; PMCID: PMC9837312.","DOI":"10.1002\/alz.12714"},{"issue":"4","key":"1939_CR54","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/bioinformatics\/btab741","volume":"38","author":"K Chetnik","year":"2022","unstructured":"Chetnik K, Benedetti E, Gomari DP, Schweickart A, Batra R, Buyukozkan M, Wang Z, Arnold M, Zierer J, Suhre K, Krumsiek J. maplet: an extensible R toolbox for modular and reproducible metabolomics pipelines. Bioinformatics. 2022;38(4):1168\u201370. https:\/\/doi.org\/10.1093\/bioinformatics\/btab741. PubMedPMID:34694386;PMCID:PMC8796365.","journal-title":"Bioinformatics"},{"issue":"2","key":"1939_CR55","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1534\/genetics.104.036699","volume":"171","author":"Y Benjamini","year":"2005","unstructured":"Benjamini Y, Yekutieli D. Quantitative trait loci analysis using the false discovery rate. Genetics. 2005;171(2):783\u201390. https:\/\/doi.org\/10.1534\/genetics.104.036699.","journal-title":"Genetics"},{"key":"1939_CR56","doi-asserted-by":"publisher","unstructured":"Samtani MN, Raghavan N, Shi Y, Novak G, Farnum M, Lobanov V, Schultz T, Yang E, DiBernardo A, Narayan VA, Alzheimer's Disease Neuroimaging I. Disease progression model in subjects with mild cognitive impairment from the Alzheimer's disease neuroimaging initiative: CSF biomarkers predict population subtypes. Br J Clin Pharmacol. 2013;75(1):146-61. https:\/\/doi.org\/10.1111\/j.1365-2125.2012.04308.x. PubMed PMID: 22534009; PMCID: PMC3555054.","DOI":"10.1111\/j.1365-2125.2012.04308.x"},{"key":"1939_CR57","doi-asserted-by":"publisher","unstructured":"Borkowski K, Pedersen TL, Seyfried NT, Lah JJ, Levey AI, Hales CM, Dammer EB, Blach C, Louie G, Kaddurah-Daouk R, Newman JW, Alzheimer's Disease Metabolomics C. Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer's disease. Alzheimers Res Ther. 2021;13(1):149. https:\/\/doi.org\/10.1186\/s13195-021-00893-6. PubMed PMID: 34488866; PMCID: PMC8422756.","DOI":"10.1186\/s13195-021-00893-6"},{"issue":"18","key":"1939_CR58","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1016\/j.neuron.2023.08.019","volume":"111","author":"Y Inoue","year":"2023","unstructured":"Inoue Y, Bamkole M, Kanekiyo T. Hepatic soluble epoxide hydrolase: a promising target for unveiling the liver-brain axis in Alzheimer\u2019s disease. Neuron. 2023;111(18):2775\u20137. https:\/\/doi.org\/10.1016\/j.neuron.2023.08.019. PubMed PMID: 37734320.","journal-title":"Neuron"},{"issue":"1","key":"1939_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-39737-8","volume":"13","author":"K Borkowski","year":"2023","unstructured":"Borkowski K, Seyfried NT, Arnold M, Lah JJ, Levey AI, Hales CM, et al. Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism. Sci Rep. 2023;13(1):13752. https:\/\/doi.org\/10.1038\/s41598-023-39737-8.","journal-title":"Sci Rep"},{"issue":"2","key":"1939_CR60","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41588-020-00773-z","volume":"53","author":"AP Wingo","year":"2021","unstructured":"Wingo AP, Liu Y, Gerasimov ES, Gockley J, Logsdon BA, Duong DM, Dammer EB, Robins C, Beach TG, Reiman EM, Epstein MP, De Jager PL, Lah JJ, Bennett DA, Seyfried NT, Levey AI, Wingo TS. Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer\u2019s disease pathogenesis. Nat Genet. 2021;53(2):143\u20136. https:\/\/doi.org\/10.1038\/s41588-020-00773-z. PubMed PMID: 33510477; PMCID: PMC8130821.","journal-title":"Nat Genet"},{"key":"1939_CR61","doi-asserted-by":"publisher","unstructured":"Benedet AL, Yu L, Labbe A, Mathotaarachchi S, Pascoal TA, Shin M, Kang MS, Gauthier S, Rouleau GA, Poirier J, Bennett DA, Rosa-Neto P, Alzheimer's Disease Neuroimaging I. CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem. Neurol Genet. 2018;4(1):e216. https:\/\/doi.org\/10.1212\/NXG.0000000000000216. PubMed PMID: 29473050; PMCID: PMC5820598.","DOI":"10.1212\/NXG.0000000000000216"},{"issue":"1","key":"1939_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01591-5","volume":"11","author":"JC Stingl","year":"2021","unstructured":"Stingl JC, Scholl C, Bosch JE, Viviani R. Genetic polymorphism of CYP2C19 and subcortical variability in the human adult brain. Transl Psychiatry. 2021;11(1):467. https:\/\/doi.org\/10.1038\/s41398-021-01591-5.","journal-title":"Transl Psychiatry"},{"issue":"10","key":"1939_CR63","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1038\/s41380-021-01251-6","volume":"26","author":"YN Ou","year":"2021","unstructured":"Ou YN, Yang YX, Deng YT, Zhang C, Hu H, Wu BS, Liu Y, Wang YJ, Zhu Y, Suckling J, Tan L, Yu JT. Identification of novel drug targets for Alzheimer\u2019s disease by integrating genetics and proteomes from brain and blood. Mol Psychiatry. 2021;26(10):6065\u201373. https:\/\/doi.org\/10.1038\/s41380-021-01251-6. PubMed PMID: 34381170.","journal-title":"Mol Psychiatry"},{"issue":"22","key":"1939_CR64","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1093\/hmg\/ddx329","volume":"26","author":"B Padhy","year":"2017","unstructured":"Padhy B, Hayat B, Nanda GG, Mohanty PP, Alone DP. Pseudoexfoliation and Alzheimer\u2019s associated CLU risk variant, rs2279590, lies within an enhancer element and regulates CLU, EPHX2 and PTK2B gene expression. Hum Mol Genet. 2017;26(22):4519\u201329. https:\/\/doi.org\/10.1093\/hmg\/ddx329.","journal-title":"Hum Mol Genet"},{"issue":"8","key":"1939_CR65","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1161\/ATVBAHA.112.251520","volume":"32","author":"NC Gupta","year":"2012","unstructured":"Gupta NC, Davis CM, Nelson JW, Young JM, Alkayed NJ. Soluble epoxide hydrolase: sex differences and role in endothelial cell survival. Arterioscler Thromb Vasc Biol. 2012;32(8):1936\u201342. https:\/\/doi.org\/10.1161\/ATVBAHA.112.251520.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1939_CR66","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1161\/STROKEAHA.116.015242","volume":"48","author":"P Corraini","year":"2017","unstructured":"Corraini P, Henderson VW, Ording AG, Pedersen L, Horvath-Puho E, Sorensen HT. Long-Term Risk of Dementia Among Survivors of Ischemic or Hemorrhagic Stroke. Stroke. 2017;48(1):180\u20136. https:\/\/doi.org\/10.1161\/STROKEAHA.116.015242. PubMedPMID:27899749;PMCID:PMC5796652.","journal-title":"Stroke"},{"key":"1939_CR67","doi-asserted-by":"publisher","unstructured":"Nuthikattu S, Milenkovic D, Norman JE, Rutledge J, Villablanca A. High Glycemia and Soluble Epoxide Hydrolase in Females: Differential Multiomics in Murine Brain Microvasculature. Int J Mol Sci. 2022;23(21). https:\/\/doi.org\/10.3390\/ijms232113044. PubMed PMID: 36361847; PMCID: PMC9655872.","DOI":"10.3390\/ijms232113044"},{"key":"1939_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/nu14173451","author":"S Nuthikattu","year":"2022","unstructured":"Nuthikattu S, Milenkovic D, Norman JE, Rutledge J, Villablanca A. The brain\u2019s microvascular response to high glycemia and to the inhibition of soluble epoxide hydrolase is sexually dimorphic. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14173451. PubMed PMID: 36079709; PMCID: PMC9460226.","journal-title":"Nutrients"},{"key":"1939_CR69","doi-asserted-by":"publisher","unstructured":"Gentreau M, Raymond M, Chuy V, Samieri C, Feart C, Berticat C, Artero S. High Glycemic Load Is Associated with Cognitive Decline in Apolipoprotein E epsilon4 Allele Carriers. Nutrients. 2020;12(12). https:\/\/doi.org\/10.3390\/nu12123619. PubMed PMID: 33255701; PMCID: PMC7761247.","DOI":"10.3390\/nu12123619"},{"issue":"6","key":"1939_CR70","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3945\/ajcn.117.162263","volume":"106","author":"MK Taylor","year":"2017","unstructured":"Taylor MK, Sullivan DK, Swerdlow RH, Vidoni ED, Morris JK, Mahnken JD, Burns JM. A high-glycemic diet is associated with cerebral amyloid burden in cognitively normal older adults. Am J Clin Nutr. 2017;106(6):1463\u201370. https:\/\/doi.org\/10.3945\/ajcn.117.162263. PubMed PMID: 29070566; PMCID: PMC5698843.","journal-title":"Am J Clin Nutr"},{"key":"1939_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.778470","volume":"12","author":"KM Wagner","year":"2021","unstructured":"Wagner KM, Yang J, Morisseau C, Hammock BD. Soluble epoxide hydrolase deletion limits high-fat diet-induced inflammation. Front Pharmacol. 2021;12: 778470. https:\/\/doi.org\/10.3389\/fphar.2021.778470. PubMed PMID: 34975481; PMCID: PMC8719166.","journal-title":"Front Pharmacol"},{"issue":"6","key":"1939_CR72","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1179\/1476830513Y.0000000092","volume":"17","author":"LR Freeman","year":"2014","unstructured":"Freeman LR, Haley-Zitlin V, Rosenberger DS, Granholm AC. Damaging effects of a high-fat diet to the brain and cognition: a review of proposed mechanisms. Nutr Neurosci. 2014;17(6):241\u201351. https:\/\/doi.org\/10.1179\/1476830513Y.0000000092. PubMed PMID: 24192577; PMCID: PMC4074256.","journal-title":"Nutr Neurosci"},{"issue":"5","key":"1939_CR73","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1021\/acscentsci.3c00052","volume":"9","author":"M Sarparast","year":"2023","unstructured":"Sarparast M, Pourmand E, Hinman J, Vonarx D, Reason T, Zhang F, Paithankar S, Chen B, Borhan B, Watts JL, Alan J, Lee KSS. Dihydroxy-Metabolites of Dihomo-gamma-linolenic Acid Drive Ferroptosis-Mediated Neurodegeneration. ACS Cent Sci. 2023;9(5):870\u201382. https:\/\/doi.org\/10.1021\/acscentsci.3c00052. PubMedPMID:37252355;PMCID:PMC10214511.","journal-title":"ACS Cent Sci"},{"key":"1939_CR74","doi-asserted-by":"publisher","unstructured":"Zimmer B, Angioni C, Osthues T, Toewe A, Thomas D, Pierre SC, Geisslinger G, Scholich K, Sisignano M. The oxidized linoleic acid metabolite 12,13-DiHOME mediates thermal hyperalgesia during inflammatory pain. Biochim Biophys Acta Mol Cell Biol Lipids. 2018;1863(7):669-78. https:\/\/doi.org\/10.1016\/j.bbalip.2018.03.012. PubMed PMID: 29625231.","DOI":"10.1016\/j.bbalip.2018.03.012"},{"issue":"13","key":"1939_CR75","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2120691119","volume":"119","author":"CB Bergmann","year":"2022","unstructured":"Bergmann CB, McReynolds CB, Wan D, Singh N, Goetzman H, Caldwell CC, Supp DM, Hammock BD. sEH-derived metabolites of linoleic acid drive pathologic inflammation while impairing key innate immune cell function in burn injury. Proc Natl Acad Sci U S A. 2022;119(13): e2120691119. https:\/\/doi.org\/10.1073\/pnas.2120691119. PubMed PMID: 35312372; PMCID: PMC9060469.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1939_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96014-2","volume":"11","author":"CB Bergmann","year":"2021","unstructured":"Bergmann CB, Hammock BD, Wan D, Gogolla F, Goetzman H, Caldwell CC, et al. TPPU treatment of burned mice dampens inflammation and generation of bioactive DHET which impairs neutrophil function. Sci Rep. 2021;11(1):16555. https:\/\/doi.org\/10.1038\/s41598-021-96014-2. PubMed PMID: 34400718; PMCID: PMC8368302.","journal-title":"Sci Rep"},{"issue":"2","key":"1939_CR77","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1161\/CIRCULATIONAHA.120.049813","volume":"143","author":"KM Pinckard","year":"2021","unstructured":"Pinckard KM, Shettigar VK, Wright KR, Abay E, Baer LA, Vidal P, et al. A novel endocrine role for the BAT-released lipokine 12,13-diHOME to mediate cardiac function. Circulation. 2021;143(2):145\u201359. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.049813. PubMed PMID: 33106031; PMCID: PMC7856257.","journal-title":"Circulation"},{"key":"1939_CR78","doi-asserted-by":"publisher","unstructured":"McReynolds C, Hammock B, Morisseau C. Regulatory lipid vicinal diols counteract the biological activity of epoxy fatty acids and can act as biomarkers and mechanisms for disease progression. Pharmacol Ther. 2023;248:108454. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108454. PubMed PMID: 37268114; PMCID: PMC10529401","DOI":"10.1016\/j.pharmthera.2023.108454"},{"key":"1939_CR79","doi-asserted-by":"publisher","unstructured":"Newman JW, Morisseau C, Hammock BD. Epoxide hydrolases: their roles and interactions with lipid metabolism. Prog Lipid Res. 2005;44(1):1-51. https:\/\/doi.org\/10.1016\/j.plipres.2004.10.001. PubMed PMID: 15748653..","DOI":"10.1016\/j.plipres.2004.10.001"},{"key":"1939_CR80","doi-asserted-by":"publisher","unstructured":"Lee HT, Lee KI, Chen CH, Lee TS. Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer's disease. J Neuroinflammation. 2019;16(1):267. https:\/\/doi.org\/10.1186\/s12974-019-1635-9. PubMed PMID: 31847859; PMCID: PMC6916033.","DOI":"10.1186\/s12974-019-1635-9"},{"key":"1939_CR81","doi-asserted-by":"publisher","unstructured":"Sun CP, Zhang XY, Zhou JJ, Huo XK, Yu ZL, Morisseau C, Hammock BD, Ma XC. Inhibition of sEH via stabilizing the level of EETs alleviated Alzheimer's disease through GSK3beta signaling pathway. Food Chem Toxicol. 2021;156:112516. https:\/\/doi.org\/10.1016\/j.fct.2021.112516. PubMed PMID: 34411643; PMCID: PMC8889936.","DOI":"10.1016\/j.fct.2021.112516"},{"key":"1939_CR82","doi-asserted-by":"publisher","unstructured":"Yang YM, Sun D, Kandhi S, Froogh G, Zhuge J, Huang W, Hammock BD, Huang A. Estrogen-dependent epigenetic regulation of soluble epoxide hydrolase via DNA methylation. Proc Natl Acad Sci U S A. 2018;115(3):613-8. https:\/\/doi.org\/10.1073\/pnas.1716016115. PubMed PMID: 29295935; PMCID: PMC5776989.","DOI":"10.1073\/pnas.1716016115"},{"key":"1939_CR83","doi-asserted-by":"publisher","unstructured":"Song YJ, Li SR, Li XW, Chen X, Wei ZX, Liu QS, Cheng Y. The Effect of Estrogen Replacement Therapy on Alzheimer's Disease and Parkinson's Disease in Postmenopausal Women: A Meta-Analysis. Front Neurosci. 2020;14:157. https:\/\/doi.org\/10.3389\/fnins.2020.00157. PubMed PMID: 32210745; PMCID: PMC7076111.","DOI":"10.3389\/fnins.2020.00157"},{"issue":"4","key":"1939_CR84","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1212\/WNL.0000000000003537","volume":"88","author":"GE Ennis","year":"2017","unstructured":"Ennis GE, An Y, Resnick SM, Ferrucci L, O\u2019Brien RJ, Moffat SD. Long-term cortisol measures predict Alzheimer disease risk. Neurology. 2017;88(4):371\u20138. https:\/\/doi.org\/10.1212\/WNL.0000000000003537. PubMedPMID:27986873;PMCID:PMC5272965.","journal-title":"Neurology"},{"key":"1939_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101171","volume":"64","author":"B Zheng","year":"2020","unstructured":"Zheng B, Tal R, Yang Z, Middleton L, Udeh-Momoh C. Cortisol hypersecretion and the risk of Alzheimer\u2019s disease: a systematic review and meta-analysis. Ageing Res Rev. 2020;64: 101171. https:\/\/doi.org\/10.1016\/j.arr.2020.101171. PubMed PMID: 32971258.","journal-title":"Ageing Res Rev"},{"key":"1939_CR86","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/bs.apha.2014.06.018","volume":"71","author":"KA Witt","year":"2014","unstructured":"Witt KA, Sandoval KE. Steroids and the blood-brain barrier: therapeutic implications. Adv Pharmacol. 2014;71:361\u201390. https:\/\/doi.org\/10.1016\/bs.apha.2014.06.018. PubMed PMID: 25307223.","journal-title":"Adv Pharmacol"},{"key":"1939_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/cells12232726","author":"E Knezevic","year":"2023","unstructured":"Knezevic E, Nenic K, Milanovic V, Knezevic NN. The role of cortisol in chronic stress, neurodegenerative diseases, and psychological disorders. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12232726. PubMed PMID: 38067154; PMCID: PMC10706127.","journal-title":"Cells"},{"issue":"2","key":"1939_CR88","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno-2022-000344","volume":"4","author":"J Holleman","year":"2022","unstructured":"Holleman J, Adagunodo S, Kareholt I, Hagman G, Aspo M, Udeh-Momoh CT, et al. Cortisol, cognition and Alzheimer\u2019s disease biomarkers among memory clinic patients. BMJ Neurol Open. 2022;4(2):e000344. https:\/\/doi.org\/10.1136\/bmjno-2022-000344. PubMed PMID: 36277478; PMCID: PMC9582323.","journal-title":"BMJ Neurol Open"},{"issue":"11","key":"1939_CR89","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1176\/appi.ajp.2008.07091532","volume":"165","author":"BK Lee","year":"2008","unstructured":"Lee BK, Glass TA, Wand GS, McAtee MJ, Bandeen-Roche K, Bolla KI, et al. Apolipoprotein e genotype, cortisol, and cognitive function in community-dwelling older adults. Am J Psychiatry. 2008;165(11):1456\u201364. https:\/\/doi.org\/10.1176\/appi.ajp.2008.07091532. PubMed PMID: 18593777; PMCID: PMC2579316.","journal-title":"Am J Psychiatry"},{"key":"1939_CR90","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.nlm.2018.08.013","volume":"155","author":"T Montoliu","year":"2018","unstructured":"Montoliu T, Hidalgo V, Pulopulos MM, Ivorra JL, Martinez MJ, Salvador A. The relationship between cortisol and cognitive function in healthy older people: the moderating role of Apolipoprotein E polymorphism. Neurobiol Learn Mem. 2018;155:297\u2013305. https:\/\/doi.org\/10.1016\/j.nlm.2018.08.013. PubMed PMID: 30130588.","journal-title":"Neurobiol Learn Mem"},{"issue":"1","key":"1939_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0190-z","volume":"12","author":"HS Futch","year":"2017","unstructured":"Futch HS, Croft CL, Truong VQ, Krause EG, Golde TE. Targeting psychologic stress signaling pathways in Alzheimer\u2019s disease. Mol Neurodegener. 2017;12(1):49. https:\/\/doi.org\/10.1186\/s13024-017-0190-z. PubMed PMID: 28633663; PMCID: PMC5479037.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1939_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-56071-9","volume":"14","author":"L Mosconi","year":"2024","unstructured":"Mosconi L, Williams S, Carlton C, Zarate C, Boneu C, Fauci F, et al. Sex-specific associations of serum cortisol with brain biomarkers of Alzheimer\u2019s risk. Sci Rep. 2024;14(1):5519. https:\/\/doi.org\/10.1038\/s41598-024-56071-9. PubMed PMID: 38448497; PMCID: PMC10918173.","journal-title":"Sci Rep"},{"key":"1939_CR93","doi-asserted-by":"publisher","unstructured":"Back M, Hansson GK. Leukotriene receptors in atherosclerosis. Ann Med. 2006;38(7):493-502. https:\/\/doi.org\/10.1080\/07853890600982737. PubMed PMID: 17101540.","DOI":"10.1080\/07853890600982737"},{"issue":"1\u20134","key":"1939_CR94","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.prostaglandins.2005.10.001","volume":"78","author":"G Hardy","year":"2005","unstructured":"Hardy G, Boizel R, Bessard J, Cracowski JL, Bessard G, Halimi S, et al. Urinary leukotriene E4 excretion is increased in type 1 diabetic patients: a quantification by liquid chromatography-tandem mass spectrometry. Prostaglandins Other Lipid Mediat. 2005;78(1\u20134):291\u20139. https:\/\/doi.org\/10.1016\/j.prostaglandins.2005.10.001. PubMed PMID: 16303623.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"10","key":"1939_CR95","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1097\/00019501-199310000-00009","volume":"4","author":"SP Allen","year":"1993","unstructured":"Allen SP, Sampson AP, Piper PJ, Chester AH, Ohri SK, Yacoub MH. Enhanced excretion of urinary leukotriene E4 in coronary artery disease and after coronary artery bypass surgery. Coron Artery Dis. 1993;4(10):899\u2013904. https:\/\/doi.org\/10.1097\/00019501-199310000-00009. PubMed PMID: 8269196.","journal-title":"Coron Artery Dis"},{"issue":"1","key":"1939_CR96","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3233\/JAD-130506","volume":"37","author":"A Di Francesco","year":"2013","unstructured":"Di Francesco A, Arosio B, Gussago C, Dainese E, Mari D, D\u2019Addario C, et al. Involvement of 5-lipoxygenase in Alzheimer\u2019s disease: a role for DNA methylation. J Alzheimers Dis. 2013;37(1):3\u20138. https:\/\/doi.org\/10.3233\/JAD-130506. PubMed PMID: 23727898.","journal-title":"J Alzheimers Dis"},{"issue":"1\u20132","key":"1939_CR97","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11064-015-1776-x","volume":"41","author":"GA Czapski","year":"2016","unstructured":"Czapski GA, Czubowicz K, Strosznajder JB, Strosznajder RP. The lipoxygenases: their regulation and implication in Alzheimer\u2019s disease. Neurochem Res. 2016;41(1\u20132):243\u201357. https:\/\/doi.org\/10.1007\/s11064-015-1776-x. PubMed PMID: 26677076; PMCID: PMC4773476.","journal-title":"Neurochem Res"},{"key":"1939_CR98","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jns.2016.01.022","volume":"362","author":"O Sery","year":"2016","unstructured":"Sery O, Hlinecka L, Povova J, Bonczek O, Zeman T, Janout V, Ambroz P, Khan NA, Balcar VJ. Arachidonate 5-lipoxygenase (ALOX5) gene polymorphism is associated with Alzheimer\u2019s disease and body mass index. J Neurol Sci. 2016;362:27\u201332. https:\/\/doi.org\/10.1016\/j.jns.2016.01.022. PubMed PMID: 26944113.","journal-title":"J Neurol Sci"},{"issue":"4","key":"1939_CR99","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1096\/fj.07-9131.com","volume":"22","author":"O Firuzi","year":"2008","unstructured":"Firuzi O, Zhuo J, Chinnici CM, Wisniewski T, Pratico D. 5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer\u2019s disease. FASEB J. 2008;22(4):1169\u201378. https:\/\/doi.org\/10.1096\/fj.07-9131.com. PubMedPMID:17998412;PMCID:PMC2698428.","journal-title":"FASEB J"},{"issue":"1","key":"1939_CR100","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/ana.22234","volume":"69","author":"J Chu","year":"2011","unstructured":"Chu J, Pratico D. 5-lipoxygenase as an endogenous modulator of amyloid beta formation in vivo. Ann Neurol. 2011;69(1):34\u201346. https:\/\/doi.org\/10.1002\/ana.22234. PubMed PMID: 21280074; PMCID: PMC3051361.","journal-title":"Ann Neurol"},{"issue":"8","key":"1939_CR101","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.biopsych.2014.06.003","volume":"77","author":"J Chu","year":"2015","unstructured":"Chu J, Li JG, Joshi YB, Giannopoulos PF, Hoffman NE, Madesh M, et al. Gamma secretase-activating protein is a substrate for caspase-3: implications for Alzheimer\u2019s disease. Biol Psychiatry. 2015;77(8):720\u20138. https:\/\/doi.org\/10.1016\/j.biopsych.2014.06.003. PubMed PMID: 25052851; PMCID: PMC4268092.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"1939_CR102","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/JAD-131223","volume":"38","author":"YB Joshi","year":"2014","unstructured":"Joshi YB, Di Meco A, Pratico D. Modulation of amyloid-beta production by leukotriene B4 via the gamma-secretase pathway. J Alzheimers Dis. 2014;38(3):503\u20136. https:\/\/doi.org\/10.3233\/JAD-131223. PubMed PMID: 24008686.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1939_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-022-01084-7","volume":"14","author":"B Ebright","year":"2022","unstructured":"Ebright B, Assante I, Poblete RA, Wang S, Duro MV, Bennett DA, Arvanitakis Z, Louie SG, Yassine HN. Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer\u2019s dementia. Alzheimers Res Ther. 2022;14(1): 152. https:\/\/doi.org\/10.1186\/s13195-022-01084-7. PubMed PMID: 36217192; PMCID: PMC9552454.","journal-title":"Alzheimers Res Ther"},{"key":"1939_CR104","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.neuroscience.2015.06.005","volume":"301","author":"L Jiang","year":"2015","unstructured":"Jiang L, Zhong J, Dou X, Cheng C, Huang Z, Sun X. Effects of ApoE on intracellular calcium levels and apoptosis of neurons after mechanical injury. Neuroscience. 2015;301:375\u201383. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.06.005. PubMed PMID: 26073697.","journal-title":"Neuroscience"},{"issue":"48","key":"1939_CR105","doi-asserted-by":"publisher","first-page":"9611","DOI":"10.1523\/JNEUROSCI.1400-19.2019","volume":"39","author":"V Rawat","year":"2019","unstructured":"Rawat V, Wang S, Sima J, Bar R, Liraz O, Gundimeda U, Parekh T, Chan J, Johansson JO, Tang C, Chui HC, Harrington MG, Michaelson DM, Yassine HN. ApoE4 alters ABCA1 membrane trafficking in astrocytes. J Neurosci. 2019;39(48):9611\u201322. https:\/\/doi.org\/10.1523\/JNEUROSCI.1400-19.2019. PubMedPMID:31641056;PMCID:PMC6880458.","journal-title":"J Neurosci"},{"key":"1939_CR106","doi-asserted-by":"publisher","unstructured":"Sienski G, Narayan P, Bonner JM, Kory N, Boland S, Arczewska AA, Ralvenius WT, Akay L, Lockshin E, He L, Milo B, Graziosi A, Baru V, Lewis CA, Kellis M, Sabatini DM, Tsai LH, Lindquist S. APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia. Sci Transl Med. 2021;13(583). https:\/\/doi.org\/10.1126\/scitranslmed.aaz4564. PubMed PMID: 33658354; PMCID: PMC8218593.","DOI":"10.1126\/scitranslmed.aaz4564"},{"key":"1939_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2023.101265","volume":"93","author":"N Liang","year":"2024","unstructured":"Liang N, Harsch BA, Zhou S, Borkowska A, Shearer GC, Kaddurah-Daouk R, et al. Oxylipin transport by lipoprotein particles and its functional implications for cardiometabolic and neurological disorders. Prog Lipid Res. 2024;93:101265. https:\/\/doi.org\/10.1016\/j.plipres.2023.101265. PubMed PMID: 37979798.","journal-title":"Prog Lipid Res"},{"key":"1939_CR108","doi-asserted-by":"publisher","unstructured":"O'Donnell VB, Aldrovandi M, Murphy RC, Kronke G. Enzymatically oxidized phospholipids assume center stage as essential regulators of innate immunity and cell death. Sci Signal. 2019;12(574). https:\/\/doi.org\/10.1126\/scisignal.aau2293. PubMed PMID: 30914483.","DOI":"10.1126\/scisignal.aau2293"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01939-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01939-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01939-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:13:34Z","timestamp":1781626414000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-025-01939-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1939"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01939-9","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"R.K-D is an inventor on several patents in the field of metabolomics and holds equity in Metabolon Inc., Chymia LCC, and Metabosensor LLC which were not involved in this study. She holds several patents on applications of metabolomics in diseases of the central nervous system. M.A. is an inventor on several patents on applications of metabolomics in diseases of the central nervous system; he holds equity in Chymia LLC and IP in PsyProtix and Atai, which were not involved in this study. G.B. is a consultant for SciNeuro Pharmaceuticals and Kisbee Therapeutics. He is also the Editor-in-Chief of Molecular Neurodegeneration. All other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}